liveBook · Manning

Chapter 6: Case Study: Small Molecule Binding to an RNA Target

What you will learn in chapter 6 of Build AI Drug Discovery Pipelines

The introduction explains why small-molecule binding to RNA is therapeutically promising but difficult to predict, and frames QSAR as a way to relate molecular descriptors to measured binding.

After this chapter you will be able to

What it builds on

Section by section

Introduction

The introduction explains why small-molecule binding to RNA is therapeutically promising but difficult to predict, and frames QSAR as a way to relate molecular descriptors to measured binding.

Key terms: RNA target, small molecule binding, selectivity, conformational flexibility, RNA-ligand structures, QSAR, descriptors, binding profile, interpretability

6.1 Small Molecule Binding to an RNA Target

Introduces HIV-1 TAR RNA as a simplified model system for a QSAR case study and explains why targeting it matters.

Key terms: HIV-1 transactivation response (TAR), model system, QSAR workflow, TAR element, HIV viral replication, antiretroviral treatments, RNA structures

6.1.1 The HIV-1 Transactivation Response (TAR) RNA Model System

This section introduces HIV-1 TAR RNA as an antiviral target and describes the small, chemically varied ligand set used for modeling.

Key terms: TAR RNA, Tat protein, TAR-Tat interaction, transcription, ligands, TAR-ligands, RNA-targeted scaffolds, binding characteristics

6.1.2 Structure: Computing Descriptors

This section expands a small RNA-binding ligand dataset into plausible protomer and conformer states, then combines their descriptors into one vector per ligand.

Key terms: protomer, protonation, tautomerization, pH range, conformer, distance geometry, ETKDG, distance bounds matrix, Universal Force Field (UFF), relative conformer energies

6.1.3 Activity: Experimentally Measuring Binding Profiles

This section explains how SPR measurements provide binding-activity responses for HIV-1 TAR ligands and why the range of those responses matters for model evaluation.

Key terms: kon, koff, KD, binding kinetics, response variables, surface plasmon resonance (SPR), immobilized target, association, dissociation, refractive index

6.2 Representative Data Splitting & Dimensionality Reduction

This section explains why descriptor choices matter before modeling and why the case study uses the paper’s published descriptor values.

Key terms: feature design, descriptors, protomers, conformers, published descriptor values

6.2.1 Data Refinement

This section refines QSAR data by log-transforming binding responses and removing redundant descriptors, while identifying a potential source of data leakage.

Key terms: log-transform, response variables, residuals, pKD, descriptors, Pearson correlation coefficient, multicollinearity, intercorrelation, response variable, training set

6.2.2 Representative Data Splitting: Kennard-Stone Algorithm

Explains why a small QSAR dataset needs a representative train/test split, how Kennard-Stone selects diverse training samples, and why high-dimensional descriptors complicate that selection.

Key terms: representative data split, applicability domain, binding activity, interpolate, Kennard-Stone algorithm, KSA, pairwise distances, training subset, descriptor space, curse of dimensionality

6.2.3 Dimensionality Reduction: Principal Component Analysis

Explains how PCA reduces descriptor dimensionality, how to choose retained components, and why its use for split design differs from its use in a predictive pipeline.

Key terms: curse of dimensionality, blessing of non-uniformity, principal components, orthogonal, variance, covariance matrix, eigenvectors, eigenvalues, k, eigenvalue criterion

6.3 QSAR Modeling: Mapping Descriptors to Measurements

This introduction previews the QSAR modeling workflow, its intended application, and a comparison with gradient boosting machines.

6.3.1 Exemplary QSAR Modeling Workflow

This section builds interpretable QSAR models for HIV TAR1 binding, explains how candidate models are selected, and cautions against overinterpreting results from a small dataset.

Key terms: QSAR, multiple linear regression, MLR, Lasso, descriptors, Topliss rule, R2, Q2, Occam’s razor, small-data regime

6.3.2 QSAR Model Interpretation

This section explains how QSAR models can inform compound design, why their interpretations need scrutiny, and how Hansch and Free-Wilson models approached structure–activity relationships.

Key terms: QSAR, descriptor, lnKoff, lnKon, a_base, a_nN, mechanistic interpretation, defined endpoint, unambiguous algorithm, applicability domain

6.4 Gradient Boosting Machines

This section previews a comparison of QSAR models with gradient boosting machines, followed by GBM theory and model-agnostic interpretation.

6.4.1 Informing the RNA-Binding Chemical Space

This section uses a gradient boosting classifier to distinguish RNA-binding from protein-binding small molecules and considers what its predictive features might reveal about RNA-binding chemical space.

Key terms: QSAR models, molecular descriptors, RNA-binding activity, protein-binding activity, GBM, XGBClassifier, Mordred, stratified 10-fold cross validation, AUPRC, LASSO

6.4.2 The XGBoost Magic Trick

This section explains how gradient boosting builds an ensemble, why it needs tuning, and what XGBoost feature-importance measures can and cannot reveal about RNA-binding predictions.

Key terms: random forests, boosting, parallel ensembles, sequential ensembles, weak learners, bias, gradient boosting, residuals, weak decision tree, loss function

6.4.3 Model-agnostic Interpretation

This section explains how sensitivity analysis and SHAP can interpret descriptor contributions to RNA-binding model predictions without restricting the choice of predictive model.

Key terms: model-agnostic interpretability, feature importance, sensitivity analysis, global sensitivity analysis, local sensitivity analysis, partial derivative analysis, finite difference, tree ensembles, Shapley values, coalition

6.5 Summary

Where this is used later

Concepts explained in this chapter

← Chapter 5: Classification: Cytochrome P450 Inhibition Chapter 7: Unsupervised Learning: Repurposing Drugs, Curating Compounds, & Screening Fragments →

These guides are generated from the text of Manning books by Manning's knowledge graph and link to the sections they draw on. The full books are available on liveBook and at manning.com.